Advertisement

#ConstructivelyDisruptive – Breaking Molds at JCF

      The world of medicine is unlike any other. Innovation and discovery science advance at a lightning-fast pace in efforts to allow improved care of patients and their loved ones. Yet, ironically, the ways we educate and communicate about new breakthroughs and challenges often transpire along old molds and via traditional platforms. Particularly in academic publishing, we sometimes encounter a passive acceptance to “the way things have been done” which may even be accompanied by resistance to new ideas:“Why double-blind reviews?”“Journal submissions must fit within the construct of prespecified types of papers only”“Social Media only represents the ‘new generation’”“Impact Factor is the true hallmark of a journal's success”
      Amidst the ongoing COVID-19 pandemic where in-person interactions are at an all-time low, there is an intense desire to connect, question the status quo, and engage in productive discourse.
      So, we've been thinking… How do we meet contemporary demands to facilitate conversation, inclusion and excitement in academic publishing? We communicate in new ways. We break old molds through creative and measured approaches that support positive outcomes. To us, constructive change means our community expands, more individuals across disciplines feel like they belong “at the table”, and trainees are inspired to join the heart failure workforce/community. Herein, we focus on impact - beyond impact factor - and at JCF we have come to call our approach to innovation #ConstructivelyDisruptive.
      JCF Ignite! is one such initiative intended to favorably transform our field (Figure). This new section is designed to serve as a platform for very concise and rigorous reports on a novel (potentially provocative) concept, analysis, insight or data presentation. The goal is to enable authors to disseminate worthwhile material in an exceptionally timely manner to enhance impactful discourse and consider paradigm shifts in the care of patients with heart failure. With dedicated senior reviewers supporting expedited peer review, we provide a novel mechanism that shortens the time to manuscript decision and publication. We are specifically interested in new ideas, innovative concepts and favorably disruptive discussions that challenge traditional dogma and provide insights to improve care for patients living with heart failure or cardiomyopathy.
      The first two JCF Ignite! papers exemplify how JCF is aiming to support enhanced scientific discourse—one involving a provocative side-by-side comparison of the effects of digoxin and SGLT2 inhibitors
      • Packer M
      • Zannad F.
      Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes.
      and one addressing the promise and challenges posed by cardiac xenotransplanation.
      • Mehra MR.
      Cardiac Xenotransplantation: Rebirth Amidst An Uncertain Future.
      These timely pieces have enhanced scientific discussion and engagement via multiple platforms including social media. We're eager to see the evolution of this program and how it can lead to improved patient care over time.
      Join us in our quest at JCF to be #ConstructivelyDisruptive!

      References

        • Packer M
        • Zannad F.
        Do the Favorable Effects of Digoxin and SGLT2 Inhibitors Really Differ in Patients with Heart Failure and a Reduced Ejection Fraction? A Provocative Side-by-Side Examination of Trial Outcomes.
        J Card Fail. 2022;
        • Mehra MR.
        Cardiac Xenotransplantation: Rebirth Amidst An Uncertain Future.
        J Card Fail. 2022;